Clinical Trials Logo

Clinical Trial Summary

Liver cirrhosis is a common diffuse and persistent liver disease often accompanied by portal hypertension, liver failure, upper gastrointestinal bleeding (UGIB), and other complications. The incidence rate of liver cirrhosis with UGIB is as high as 30-40%, which is related to the rupture bleeding of gastroesophageal varices (GOV), hepatogenic ulcer, portal hypertensive gastropathy, hepatic gastrointestinal failure, etc


Clinical Trial Description

In the case of UGIB in patients with liver cirrhosis, acute peripheral circulatory failure may suddenly occur, resulting in decreased blood perfusion in liver tissues, often accompanied by clinical manifestations such as blood volume decline, melena, and haematemesis. This disease progresses rapidly, with a mortality rate of above 10% if not treated promptly Timing of endoscopy in the management of acute upper gastrointestinal bleeding (AUGIB) has been a subject of perennial debate. Despite remarkable advancements in endoscopic treatments and substantial efforts in reducing mortality, the overall in-hospital mortality rate associated with UGIB is still estimated to be 10%. Several studies have investigated the clinical impact of urgent (within 6 h of presentation) or early (within 12 h) endoscopy on mortality in patients with UGIB. Some studies showed no significant difference in mortality rate between urgent and elective endoscopy groups among high-risk patients with acute UGIB In contrast, others found that urgent endoscopy was associated with a lower mortality rate in high-risk patients with acute non-variceal UGIB. Most of the previous studies included highly selected patients with non-variceal UGIB or those at a high risk. However, given that the definitive diagnosis is made after endoscopic examination, these studies may not reflect real-world clinical practice. Furthermore, it is often challenging to predict the cause of bleeding and to identify patients at high risk who require intensive care based on their symptoms and the information obtained in the emergency room ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06214234
Study type Interventional
Source Assiut University
Contact Shaden Kelany, MSc
Phone 01024817165
Email shadenahmed997@gmail.com
Status Not yet recruiting
Phase N/A
Start date February 1, 2024
Completion date February 28, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06017102 - Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices N/A
Recruiting NCT03624517 - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices Phase 4
Recruiting NCT03989973 - Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
Completed NCT05485714 - Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
Completed NCT01851252 - MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy Phase 1
Completed NCT01360515 - A Study of Disposable Transnasal Esophagoscope N/A
Recruiting NCT04602663 - Optimal Time for Follow up After Variceal Band Ligation N/A
Recruiting NCT04499898 - Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding Phase 2/Phase 3
Completed NCT00331188 - Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Phase 3
Enrolling by invitation NCT02767206 - Evaluation of Gastroesophageal Varices by Transnasal Endoscopy. N/A
Enrolling by invitation NCT05781828 - Noninvasive Methods For Prediction of Esophageal Varices in Children
Not yet recruiting NCT05199038 - Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study Phase 4
Recruiting NCT02740166 - Preventing Recurrent Bleeding After Eradication of Esophageal Varices Phase 4
Completed NCT01893541 - PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES? Phase 4
Terminated NCT00485290 - Effect of Meal on Portal and Esophagus Variceal Pressure N/A
Completed NCT01079416 - Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices N/A
Completed NCT01188733 - Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis Phase 1/Phase 2
Not yet recruiting NCT04254822 - HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients N/A
Recruiting NCT03212872 - Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding N/A
Completed NCT03748563 - Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis N/A